Paper9302365
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
Mourits MP and 3 others. Clin Endocrinol (Oxf), 1997. Cited by 789 papers, by iCite.
Cite this record
ConductScience Library. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Papers, record 9302365. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9302365
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graves Disease | Major topic |
| Severity of Illness Index | Major topic |
| Adult | |
| Aged | |
| Anti-Inflammatory Agents | |
| Conjunctivitis | |
| Double-Blind Method | |
| Exophthalmos | |
| Eye Movements | |
| Female | |
| Humans | |
| Inflammation | |
| Male | |
| Middle Aged | |
| Predictive Value of Tests | |
| Prednisolone | |
| Prognosis | |
| Prospective Studies | |
| Sensitivity and Specificity | |
| Visual Acuity |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 9302366 | Clinical activity score as a guide in the management of patients with Graves' orbitopathy. | https://conductscience.org/library/papers/9302366 |
Source PubMed
Cited by377
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 789 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964047 | Nocturnal sleep duration, clinical activity score, and thyroid functional remission after radioactive iodine therapy in Graves' disease with thyroid-associated ophthalmopathy. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42964047 | PubMed |
| 42941843 | Thyroid Eye Disease in the Teprotumumab Era: Pathophysiology, Clinical Activity Assessment, and an Updated Therapeutic Landscape. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941843 | PubMed |
| 42895280 | Systemic Vascular Contributions to Inactive Dysthyroid Optic Neuropathy: Beyond Mechanical Compression. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42895280 | PubMed |
| 42865923 | Management of pregnancy in patients with Graves' disease secondary to alemtuzumab: a case series and literature review. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42865923 | PubMed |
| 42776255 | Pupillometric alterations in Graves' disease: Beyond thyroid functional status. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/42776255 | PubMed |
| 42684865 | WSOPRAS and ITEDS Consensus Statement on the Assessment and Management of Thyroid Eye Disease. | Ophthalmic Plast Reconstr Surg | 2026 | https://conductscience.org/library/papers/42684865 | PubMed |
| 42657997 | Machine Learning-Based Cytokine Endotyping of Thyroid Eye Disease. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42657997 | PubMed |
| 42599029 | Gut Microbial Metabolite Indole-3-Acetic Acid Exerts Protective Effects by Regulating Orbital Fibroblast Fibrosis in Thyroid Eye Disease. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42599029 | PubMed |
| 42572712 | Transcutaneous Levator Aponeurosis Recession Without Spacer Grafts for Upper Eyelid Retraction: A Five-Case Series. | Cureus | 2026 | https://conductscience.org/library/papers/42572712 | PubMed |
| 42541186 | Dysthyroid Optic Neuropathy in Graves' Orbitopathy: Insights from a Single Centre and Limitations of the Radiological Indices. | Indian J Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42541186 | PubMed |
| 42380591 | Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42380591 | PubMed |
| 42371852 | Correlations between Clinical Activity Score and Serological and Radiological Data in Treatment-naïve Ethnic Han Chinese Thyroid Eye Disease. | Ophthalmic Res | 2026 | https://conductscience.org/library/papers/42371852 | PubMed |
| 42287316 | Kaempferol: advances in biosynthesis, molecular mechanisms, and therapeutic applications. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42287316 | PubMed |
| 42281219 | A Korean Clinical Practice Framework for Thyroid Eye Disease: Integrating International Recommendations with Survey-Informed Consensus. | Endocrinol Metab (Seoul) | 2026 | https://conductscience.org/library/papers/42281219 | PubMed |
| 42275591 | The hidden impact of smoking in thyroid eye disease: a link between selenium deficiency, autoimmunity, and retinal microvasculature. | Arch Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42275591 | PubMed |
| 42138630 | Treatment outcomes in patients with relapsed Graves' disease. | Arch Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42138630 | PubMed |
| 42120678 | Benefits of thermal imaging in orbital inflammation disorders. | J Ophthalmic Inflamm Infect | 2026 | https://conductscience.org/library/papers/42120678 | PubMed |
| 42093381 | A Consensus-Based Clinical Activity Score Atlas for Thyroid Eye Disease in East Asian Patients: The Korean Society of Ophthalmic Plastic and Reconstructive Surgery Initiative. | Korean J Ophthalmol | 2026 | https://conductscience.org/library/papers/42093381 | PubMed |
| 42045866 | Retinal hemodynamics and oxygen metabolism: potent inflammatory indicators for thyroid eye disease. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42045866 | PubMed |
| 41939739 | Teprotumumab N01 for thyroid eye disease in China: clinical outcomes and quantitative MRI correlations. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41939739 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9302365
GET https://conductscience.org/api/papers/v1/9302365/cited_by?page=2